Heart Failure - Post Myocardial Infarction (MI): Eplerenone is indicated, in addition to standard therapy, to reduce the risk of cardiovascular (CV) mortality and morbidity in stable patients with left ventricular dysfunction (left ventricular ejection fraction [LVEF] ≤40%) and clinical evidence of heart failure after recent myocardial infarction (MI).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
